Ranitidine
- Product NDC
- 43353-445
- 11-digit product format
- 433530445
- Labeler code
- 43353
- Product ID
- 43353-445_515aa4a3-308a-4d12-915e-5684210081eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2009-12-16
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-445 | RANITIDINE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC | 20171127_f4b81ce4-7fad-4a2b-a9a7-bc646d57543a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-445-60 | 43353044560 | 90 TABLET in 1 BOTTLE (43353-445-60) | 90 tablet | 2010-06-29 | 0000-00-00 | No | No | Current |
| 43353-445-80 | 43353044580 | 180 TABLET in 1 BOTTLE (43353-445-80) | 180 tablet | 2009-12-23 | 0000-00-00 | No | No | Current |